Developing Legislation

The Health and Care Act 2022 (Section 180)

The Health and Care Act 2022 (Section 180) (Licensing of Cosmetic Procedures)

The Health and Care Act 2022 (Section 180) enables the UK Government to establish a mandatory licensing scheme for non-surgical cosmetic procedures in England, aiming to improve safety, hygiene, and practitioner standards. The scheme will cover procedures like dermal fillers and botulinum toxin, requiring both practitioners and premises to be licensed.

Timeline to Section 180

2026
APPG Report
APPG report calls for urgent reform

The APPG on Beauty, Aesthetics and Wellbeing warns that the fast‑growing non‑surgical aesthetics sector is operating without consistent safeguards, leaving consumers exposed to variable training, uneven local authority powers and poorly controlled products; it urges urgent reform through a mandatory national licensing scheme, minimum training and competence standards, clearer statutory guidance for regulators and tighter product controls, including reclassifying dermal fillers as Prescription Only Medicines.

2023–2025
Implementation
Implementation pathway – consultations and government response

The DHSC’s 2 September 2023 consultation on licensing non‑surgical cosmetic procedures proposed a new oversight system in England, with local authorities licensing lower‑risk treatments and the CQC regulating the highest‑risk procedures. Across 2023–2024 more than 11,800 responses were analysed, informing the Government’s position. In its 7 August 2025 response, the Government confirmed it will classify high‑risk procedures—such as liquid Brazilian butt lifts—as CQC‑regulated activities restricted to specified regulated healthcare professionals, signalling a shift toward tighter statutory control of the aesthetics sector.

2019–2021
Political focus & APPG inquiry
Political focus, APPG inquiry and under 18s legislation

Support for statutory regulation of non‑surgical cosmetic treatments grew from 2019 to 2021: NHS England’s proposals for new regulatory powers gained backing from major unions; the JCCP’s 2020 plan argued voluntary registration was inadequate and called for compulsory licensing; the Botulinum Toxin and Cosmetic Fillers (Children) Bill introduced offences for treating under‑18s while ministers signalled wider licensing was being explored; and the APPG’s 2021 final report recommended national training standards, regulated qualifications, a licensing framework, prescription‑only fillers, psychological screening and advertising controls, which DHSC confirmed would shape its regulatory review.

2021-2022
Health and Care Bill
Health and Care Bill and creation of section 180

The 2021 amendment to the Health and Care Bill introduced powers for a mandatory national licensing scheme for aesthetic non‑surgical cosmetic procedures, making it an offence to practise without a licence, a direction reinforced by committee‑stage discussions on improving safety and oversight. These proposals were realised in July 2022 when Section 180 of the Health and Care Act 2022 came into force, enabling regulations to license practitioners and premises for specified cosmetic procedures—defined broadly to cover injections, substances penetrating the epidermis, needles, threads and the application of light, electricity, cold or heat, while excluding surgical and dental work.

2015-2018
Voluntary Regulation
Education standards, voluntary regulation and ethical framing

Between 2015 and 2018, the UK’s regulatory direction for non‑surgical cosmetic procedures was shaped by three linked developments: Health Education England introduced the first national competency‑based training framework for cosmetic and hair restoration practitioners, calling for statutory regulation and a voluntary register; the Joint Council for Cosmetic Practitioners launched in 2018 as a PSA‑accredited voluntary regulator adopting those standards and operating practitioner and training provider registers; and the Nuffield Council on Bioethics’ 2017 report highlighted ethical and social risks, recommending a ban on procedures for under‑18s outside multidisciplinary care, stronger public awareness, and quality‑marked practitioner registers.

2013
Associated research reports
Associated research reports

Two companion research studies explored public and professional perspectives on cosmetic interventions: one examined how the general public and practitioners perceive the risks and regulatory needs of cosmetic treatments, while the other focused specifically on teenage girls, highlighting the particular vulnerabilities and social pressures young people face in relation to cosmetic procedures.

2010–2012
Market growth and early concern
Market growth and early concern

Between 2010 and 2012, the UK saw a sharp rise in cosmetic interventions, with non‑surgical treatments such as fillers, toxins and lasers dominating the market, and this period of rapid growth was followed in 2012 by the PIP breast implant scandal, where failures in product quality and aftercare exposed significant regulatory gaps and intensified concerns about the safety and oversight of both surgical and non‑surgical cosmetic procedures.

2013
Keogh Review
Foundational regulatory critique

In April 2013, the Keogh Review for the Department of Health concluded that non‑surgical cosmetic interventions—particularly dermal fillers—were “almost entirely unregulated”, calling for a comprehensive legislative framework supported by stronger product controls, clearer practitioner standards and effective redress mechanisms.

Latest Terrorism (Protection of Premises) Act 2025 News